Conquering Diseases

Study Of An Investigational Drug For Advanced Non-Squamous Non Small Cell Lung Cancer

Description

Seeking men and women whose non-squamous non small cell lung cancer (NSCLC) has progressed after chemotherapy for a study of an investigational drug alone or in combination with an immune drug compared to the usual chemotherapy treatment.

Overview

Participants in this study will be randomly chosen to receive the investigational drug, the investigational drug in combination with an immune drug, or the standard chemotherapy.

What we're hoping for

We are studying whether the investigational drug alone or in combination is effective in reducing the risk of non-squamous non small cell lung cancer (NSCLC) from progressing or spreading.

Additional Information

ClinicalTrials.gov Identifier: NCT04310007

 Principal Investigator

William  Walsh, MD

UMass Memorial Health Care

 Study Contact

The Cancer  Research Office

508-856-3216

Cancer.research@umassmed.edu

 Location

UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989